EcoDrugPlus

Ensembl ID : ENSACIG00000008384
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSACIG00000014957
Gene Symbol: -
1 Cross references
121 Possible Orthologues:

Ensembl ID : ENSACIG00000015534
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSACIG00000006911
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSACIG00000009032
Gene Symbol: RPL19
1 Cross references
324 Possible Orthologues:

Ensembl ID : ENSACIG00000017729
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSACIG00000010687
Gene Symbol: -
Cross references: -
144 Possible Orthologues:

Ensembl ID : ENSACIG00000019581
Gene Symbol: RPL36
1 Cross references
407 Possible Orthologues:

Ensembl ID : ENSACIG00000015530
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSACIG00000011429
Gene Symbol: TIE1
1 Cross references
206 Possible Orthologues:

Ensembl ID : ENSACIG00000008969
Gene Symbol: RPL18A
1 Cross references
369 Possible Orthologues:

Ensembl ID : ENSACIG00000015641
Gene Symbol: -
Cross references: -
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).